Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 47,186 | 45,315 | 38,329 | 40,810 | 44,329 |
| Receivables | 94,729 | 95,942 | 83,698 | 83,278 | 67,703 |
| Other current assets | 74,895 | 525,705 | 74,637 | 53,961 | 35,135 |
| TOTAL | $221,232 | $668,487 | $199,264 | $180,590 | $151,224 |
| Non-Current Assets | |||||
| PPE Net | 2,177,336 | 1,816,794 | 2,300,574 | 2,218,676 | 2,106,880 |
| Investments And Advances | 465,041 | 473,792 | 444,741 | 275,826 | 249,665 |
| Intangibles | 21,125 | 21,527 | 21,978 | 22,429 | 22,973 |
| Other Non-Current Assets | 33,181 | 32,017 | 32,608 | 22,937 | 24,389 |
| TOTAL | $2,696,683 | $2,344,130 | $2,799,901 | $2,539,868 | $2,403,907 |
| Total Assets | $2,917,915 | $3,012,617 | $2,999,165 | $2,720,458 | $2,555,131 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 318,664 | 311,381 | 194,563 | 159,599 | 168,928 |
| Accounts payable and accrued liabilities | 64,252 | 81,510 | 265,209 | 190,788 | 140,946 |
| Accrued Expenses | 19,869 | 25,069 | 18,882 | 17,206 | 11,245 |
| TOTAL | $408,001 | $425,533 | $486,999 | $375,119 | $328,367 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,764,695 | 1,847,633 | 1,777,420 | 1,679,492 | 1,567,339 |
| Deferred Revenues | 5,216 | 7,573 | 8,345 | 7,526 | 7,248 |
| Other Non-Current Liabilities | 1,961 | 0 | 0 | 0 | 0 |
| TOTAL | $1,805,605 | $1,885,952 | $1,815,697 | $1,716,591 | $1,603,944 |
| Total Liabilities | $2,213,606 | $2,311,485 | $2,302,696 | $2,091,710 | $1,932,311 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,935 | 18,712 | 19,306 | 19,306 | 20,494 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | 487,479 | 471,112 | 453,912 | 433,906 | 414,757 |
| Other shareholders' equity | 97,271 | 97,352 | 97,486 | 48,630 | -5,812 |
| TOTAL | $704,309 | $701,132 | $696,469 | $628,748 | $622,820 |
| Total Liabilities And Equity | $2,917,915 | $3,012,617 | $2,999,165 | $2,720,458 | $2,555,131 |